9:00 am

Welcome address
Otmar Kloiber, Secretary General of the World Medical Association

Session 1

Chairs:
Ramin Parsa-Parsi, Chair of the WMA DoH Workgroup, German Medical Association
Torunn Janbu, Chair of the Ethics Committee of the WMA, Norwegian Medical Association

9:15 am

Introduction
Urban Wiesing, WMA DoH Workgroup Scientific Board, University of Tuebingen, Germany

9:40 am

The Future of the Declaration of Helsinki
Ruth Macklin, Albert Einstein College of Medicine, USA

10:05 am

Helsinki in the Age of Human Rights
Aurora Plomer, Sheffield Institute of Biotechnology, Law and Ethics University of Sheffield, UK

10:30 am

Break

Session 2

Chairs:
Masami Ishii, Vice-Chairman of the WMA Council, Japan Medical Association
Miguel R. Jorge, WMA DoH Workgroup, Brazilian Medical Association

11:00 am

On the relevance of embedding clinical equipoise in the Declaration of Helsinki
Rieke van der Graaf, Julius Center, University Medical Center Utrecht Netherlands

11:25 am

Should the Declaration of Helsinki become more "risk‐based"?
Annette Rid, Institute of Biomedical Ethics, University Hospital Zurich Switzerland

11:50 am

ECRIN proposals for amendments to the Declaration of Helsinki: ethics committees, transparency,
and choice of comparator
Jacques Demotes-Mainard, European Clinical Research Infrastructures Network (ECRIN)

12:15 pm

The new Declaration of Helsinki and the use of placebos in clinical trials: the controversy still remains
Maria-Sharmila Sousa, Federal University of São Paulo, Paulista Medical School, Brazil

12:40 pm

Lunch

Session 3

Chairs:
Peter Carmel, WMA DoH Workgroup, American Medical Association
Poul Jaszczak, WMA DoH Workgroup, Danish Medical Association

2:00 pm

Ancillary care, the Declaration of Helsinki and the obligations of global justice
John McMillan, School of Medicine, Flinders University, Australia

2:25 pm

The impact of paragraph 25 on informed consent for biobank samples
Flora Colledge, Institute for Biomedical Ethics, University of Basel, Switzerland

2:50 pm

Refining the Declaration of Helsinki's additional protections for research in children
Anna Westra, Erasmus University Medical Center, The Netherlands

3:15 pm

Break

Session 4

Chairs:
Jeff Blackmer, WMA DoH Workgroup Scientific Board, Canadian Medical Association
Otmar Kloiber, Secretary General of the World Medical Association

3:45 pm

Considering research on neuro-enhancement in the next revision of the Declaration of Helsinki
Saskia Nagel, Institute of Cognitive Science, University of Osnabrueck Germany

4:10 pm

Closing

4:30 pm

End